Renuka Ekka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Renuka Ekka has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Bharti Ahirwar
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Koni, Bilaspur, Chhattisgarh, 495009 - India
1 shared publication- Bharti Ahirwar
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India
1 shared publication - Kavita Naik
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India
1 shared publication Shashikala Bhagat
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Koni, Bilaspur, Chhattisgarh, 495009 - India
1 shared publicationShubham Kumar Sahu
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya, Koni, Bilaspur, Chhattisgarh, 495009 - India
1 shared publication- Siddharth Singh Chandel
Department of Pharmacy, Guru Ghasidas Vishwavidyalaya (A Central University), Bilaspur, India
1 shared publication
Latest Publications
- 28 February 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (3) , 231
Integrated In-silico and Experimental investigation of Centella asiatica (L.) Extract-Based Phytosomal Formulation Targeting FYN Kinase for Neuroprotective, Anti-Inflammatory and Antioxidant Potential
- 28 February 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (3) , 231
Integrated In-silico and Experimental investigation of Centella asiatica (L.) Extract-Based Phytosomal Formulation Targeting FYN Kinase for Neuroprotective, Anti-Inflammatory and Antioxidant Potential
- 31 January 2026
- Published by A and V Publications in Research Journal of Pharmacognosy and Phytochemistry
- Vol. 18 (1) , 96-105
Centella asiatica (L.) as a Neuroprotective agent in Alzheimer’s Disease: A Focus on Mitochondrial Bioenergetics and Antioxidant Pathways
Alzheimer’s disease is a progressive neurodegenerative disorder marked by cognitive decline, amyloid-beta accumulation, tau hyperphosphorylation, and chronic oxidative stress. Emerging evidence highlights mitochondrial dysfunction and impaired bioenergetics as central contributors to Alzheimer's disease pathogenesis. Centella asiatica a medicinal herb widely used in traditional systems of medicine, has demonstrated promising neuroprotective properties through its rich phytochemical profile, particularly triterpenoids such as asiaticoside and madecassoside. This review systematically explores the role of Centella asiatica in modulating mitochondrial bioenergetics and antioxidant pathways in the context of Alzheimer’s disease. Centella asiatica enhances mitochondrial function by upregulating ATP synthesis, preserving mitochondrial membrane potential, and promoting biogenesis via PGC-1α activation. Concurrently, it activates the Nrf2 signalling pathway, leading to increased expression of endogenous antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase. These mechanisms collectively reduce reactive oxygen species (ROS), mitigate lipid peroxidation, and prevent neuronal apoptosis. Preclinical studies support Centella asiatica's efficacy in improving cognitive performance, reducing neuroinflammation, and protecting against neurotoxicity. Although clinical data remain limited, the safety profile and multi-targeted action of Centella asiatica position it as a promising candidate for adjunctive therapy in Alzheimer’s disease. Further translational research and clinical trials are warranted to validate its therapeutic potential and optimise its pharmacological application.
- 31 January 2026
- Published by A and V Publications in Research Journal of Pharmacognosy and Phytochemistry
- Vol. 18 (1) , 96-105
Centella asiatica (L.) as a Neuroprotective agent in Alzheimer’s Disease: A Focus on Mitochondrial Bioenergetics and Antioxidant Pathways
Alzheimer’s disease is a progressive neurodegenerative disorder marked by cognitive decline, amyloid-beta accumulation, tau hyperphosphorylation, and chronic oxidative stress. Emerging evidence highlights mitochondrial dysfunction and impaired bioenergetics as central contributors to Alzheimer's disease pathogenesis. Centella asiatica a medicinal herb widely used in traditional systems of medicine, has demonstrated promising neuroprotective properties through its rich phytochemical profile, particularly triterpenoids such as asiaticoside and madecassoside. This review systematically explores the role of Centella asiatica in modulating mitochondrial bioenergetics and antioxidant pathways in the context of Alzheimer’s disease. Centella asiatica enhances mitochondrial function by upregulating ATP synthesis, preserving mitochondrial membrane potential, and promoting biogenesis via PGC-1α activation. Concurrently, it activates the Nrf2 signalling pathway, leading to increased expression of endogenous antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase. These mechanisms collectively reduce reactive oxygen species (ROS), mitigate lipid peroxidation, and prevent neuronal apoptosis. Preclinical studies support Centella asiatica's efficacy in improving cognitive performance, reducing neuroinflammation, and protecting against neurotoxicity. Although clinical data remain limited, the safety profile and multi-targeted action of Centella asiatica position it as a promising candidate for adjunctive therapy in Alzheimer’s disease. Further translational research and clinical trials are warranted to validate its therapeutic potential and optimise its pharmacological application.